Clinical decision support system or CDSS analyzes the healthcare data to assist in the process of making clinical decisions. This system is nothing but an adaptation of the popular decision making support systems. CDSS is commonly used by nurses, physicians and other healthcare researchers and workers. Assistance in preparing diagnostic reports and use in the data mining proceedings are some of the basic characteristics of these decision support systems. The global clinical decision support system market is expected to maintain healthy growth during the forecasting period. Rising demand and advancing technology in the systems are the vital elements responsible for the rising demand and growth of the industry.
Segmentation in CDSS Market
Analysis of all the segments of the industry for clinical decision support systems provide information about the integrated and standard CDSS solutions, which are the two major classes of the global market. The industry is segmented into different products, models, applications, components, delivery modes, clinical decision support and geography. Following are the details of the same:
- Products: Integrated and standard CDSS
- Models: knowledge based and non-knowledge based CDSS
- Applications: Drug interactions, allergy alerts, guidelines, reminders, dosage support, etc.
- Components: Software, hardware and services
- Delivery: On-premise, web based and cloud based
- Decision support: 500+, 400-499, 300-399, 200-299, 100-199, and <100 beds
- Geography: Europe, Asia, North America and RoW
Forecasting Reports from 2013-18
Inference mechanism, medical knowledge base, and communicator are the three basic components of the clinical decision support system market. Emergence of could computing systems and strong backing from governments and authorities are some of the major drivers for the global market. Rising demand from emerging regions like Asia Pacific, Middle East, Latin America, and Africa are also driving the industry towards healthy growth in terms of revenue, production, and global presence. According to the market research reports, the industry is anticipated to make healthy growth at a projected CAGR of over 10% from 2013 to 2018.
During the projected growth period, the market is expected to become worth more than $550 million by 2018. In terms of demand and presence across different geographic regions, North America is estimated to dominate the global industry for clinical decision support systems. Advent of cognitive computing-based supercomputers and such other advanced technologies are expected to revolutionize the industry. Emerging regions like Asia Pacific on the other hand are estimated to witness strong growth from 2014 to 2018. As a result, the region has become a hotspot for the potential investors.